Home › High Blood Pressure › New York › Buffalo
High Blood Pressure clinical trials in Buffalo, NY
4 studies for High Blood Pressure are looking for participants at sites in and around Buffalo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Rochester Clinical Research - Buffalo, Buffalo
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- RCR - Buffalo, Buffalo
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Buffalo
Global Paradise System US Post Approval Study
RecruitingObservational study
- University at Buffalo, Buffalo
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL22 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Houston, TX11 studies
- Birmingham, AL11 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- Durham, NC10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Buffalo
- Cancer (all types)19 studies
- Acute Myeloid Leukemia19 studies
- Non-Small Cell Lung Cancer18 studies
- Lung Cancer16 studies
- Breast Cancer16 studies
- Ovarian Cancer13 studies
- Prostate Cancer11 studies
- Metastatic Cancer11 studies
- Multiple Myeloma10 studies
- Melanoma10 studies
- Obesity9 studies
- Burkitt Lymphoma8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.